Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis.
Gabriel Marinheiro Dos Santos BezerraBeatriz AraújoGabriel de Almeida MonteiroMarianna LeiteAntonio MutarelliArtur Menegaz de AlmeidaJoaquim Francisco Cavalcante-NetoAndré RiveraAgostinho Camara PinheiroJoão Paulo Motta TellesPublished in: Journal of neurology (2024)
DAPTs were superior to aspirin in preventing recurrence or ischemic stroke. Although no significant difference was observed between DAPTs, ticagrelor plus aspirin may be related to worse major bleeding results, including intracranial bleeding. Ticagrelor plus aspirin is a considerable option for patients after a minor stroke or TIA.
Keyphrases
- optical coherence tomography
- antiplatelet therapy
- percutaneous coronary intervention
- atrial fibrillation
- acute coronary syndrome
- optic nerve
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- end stage renal disease
- systematic review
- cerebral ischemia
- ejection fraction
- chronic kidney disease
- coronary artery disease
- newly diagnosed
- low dose
- type diabetes
- peritoneal dialysis
- randomized controlled trial
- oxidative stress
- brain injury
- ischemia reperfusion injury
- cardiovascular events